| HOME >> BIOLOGY >> TECHNOLOGY |
the Legg Mason Partners Variable Equity Trust and a director of LMP
Real Estate Income Fund, Inc. and Western Asset Municipal High Income
Fund, Inc.
-- John J. Jones. Mr. Jones served as Senior Vice President and General
Counsel of Argosy Gaming Company from January 2004 to October 2005, as
Vice Chairman and General Counsel of Legal Advantage Services from
December 2002 to January 2004, as Executive Vice President and General
Counsel of RCN Corporation from July 1998 to December 2002 and is
currently the Managing Director of J3 Capital and Executive Vice
President of Imaging Advantage LLC.
-- Loring W. Knoblauch. Mr. Knoblauch served as President and Chief
Executive Officer of Underwriters Laboratories, Inc. from April 2001 to
December 2004, as President and Chief Executive Officer of Talon
Automated Equipment Company from 1997 to 2001, as President of
Honeywell Asia Pacific from 1986 to 1992 and is currently a member of
the Operating Advisory Board of Prism Capital, Inc.
-- Michael L. Kranda. Mr. Kranda served as a Managing Director of Vulcan
Venture Capital from September 2003 to December 2006, as Chief
Executive Officer and President of Oxford GlycoSciences from July 1996
to July 2002 and is currently a consultant for Vulcan Venture Capital.
In addition, Roche intends to seek stockholder approval to amend
Ventana's bylaws to eliminate Ventana's classified board and to remove all
of the Ventana directors, other than the four Class III directors elected
at the 2008 Annual Meeting. If stockholders approve the elimination of the
classified board and removal of directors, Roche intends to seek
stockholder approval to amend Ventana's bylaws to reduce the size of the
Board of Directors from 10 to seven members and to elect the following
candidates to
'/>"/>
| SOURCE Roche Copyright©2007 PR Newswire. All rights reserved |